Acquisition

With a key acquisition and a new regulatory license, Hong Kong's Payment Asia Group is consolidating the Canadian fintech market to build a powerful new payments bridge.

PowerBank is reacquiring two NY solar projects in a $32.5M move, signaling a strategic pivot to asset ownership to capture recurring revenue before key federal credits expire.

As AI firms ditch per-seat pricing, Stigg's buyout of Received.ai aims to fuse contracts, usage, and invoicing into a single, automated revenue engine.

The dermatology giant posts strong revenue but dips in profit, channeling funds into high-impact acquisitions and R&D for underserved skin conditions.

Anil Yadav's journey from fry cook to the new owner of Denny's is more than a feel-good story—it's a high-stakes bet on operational discipline.

UCC Environmental's buyout of Cast Steel Products creates a formidable player in wear-resistant parts, blending environmental tech with deep metallurgy.

Pilgrim's Europe's acquisition of Walkers Deli & Sausage is more than a deal; it's a strategic realignment of the UK's food supply chain. What does it mean?

JLL Partners' acquisition of Life Couriers and the appointment of a new CEO signal a major bet on the future of time-critical healthcare logistics.

OceanaGold makes its Australian debut, acquiring Ausgold for A$776M to develop the Katanning Gold Project. A deep dive into the deal's strategic impact.

In a strategic pivot, Skye Bioscience acquires Redx Pharma, creating Fibrx Therapeutics—a new Nasdaq-listed player armed with $125M and a bold plan.

With assets soaring 290% and revenue nearly doubling, PMGC Holdings' pivot to strategic acquisitions in aerospace and tech is paying off spectacularly.

Quince Therapeutics bets its future on an inhaled lung disease drug, LAM-001, after acquiring Orphai and securing a $115M financing to fuel its new mission.

The deal signals a major food tech trend: consolidation for all-in-one platforms versus specialization, as iFoodDS doubles down on traceability.

Plunging revenues and a staggering net loss push IM Cannabis to the edge, forcing a desperate and bizarre strategic pivot from medical marijuana to military drones.

With mounting losses and a CEO's unyielding optimism, activist investors issue an ultimatum: take proteomics firm Seer private or face the consequences.

With its 67th acquisition, Daybright Financial isn't just buying a firm; it's cornering the high-stakes ACA compliance market amid rising penalties.

As automation commoditizes ad buying, agencies like New Engen are betting big on 'creative-led growth.' A deep dive into the strategy drawing brands like Uber and MeUndies.

With strong Q2 results as a tailwind, Interlink is making a bold move with a transformative acquisition and new sensor tech. But can it execute?

CAI Software's acquisition of LLumin isn't just another deal. It's a strategic move to build an integrated platform that tackles manufacturing's biggest cost.

A Kansas City CCRC's pivot from hefty entrance fees to a rental model reveals a strategic play by new owner Lapis Advisers, a blueprint for the industry.